AKT1 and cancer: PTEN is the negative regulator of PI3K/Akt signaling pathway, which is frequently activated in various cancer cells and associated with chemoresistance (Chen et al., 2014; Li et al., 2015; Chen et al., 2020; Yang et al., 2020).